Edwina Woodbury - Nu Skin Independent Director
| NUS Stock | USD 6.55 0.01 0.15% |
Director
Ms. Edwina D. Woodbury is an Independent Director of Nu Skin Enterprises, Inc. Ms. Woodbury was President and Chief Executive Officer of The Chapel Hill Press, Inc., a publishing services company, since 1999. Ms. Woodbury has over 20 years of experience in the direct selling and personal care products industries, having served at Avon Products, Inc. as Chief Financial and Administrative Officer and in other finance and operations positions from 1977 to 1998. From 1997 to 2015, Ms. Woodbury served as a member of the board of directors of RadioShack Corporationrationration, a retail consumer electronics company. In addition, from 2005 to 2010, Ms. Woodbury served as a member of the board of directors of R.H. Donnelley Corporationrationration, a publishing and marketing company, and from 2000 to 2005, she served as a director of Click Commerce, Inc., a research solutions company since 2015.
| Age | 68 |
| Tenure | 10 years |
| Address | 75 West Center Street, Provo, UT, United States, 84601 |
| Phone | 801 345 1000 |
| Web | https://www.nuskin.com |
Edwina Woodbury Latest Insider Activity
Tracking and analyzing the buying and selling activities of Edwina Woodbury against Nu Skin stock is an integral part of due diligence when investing in Nu Skin. Edwina Woodbury insider activity provides valuable insight into whether Nu Skin is net buyers or sellers over its current business cycle. Note, Nu Skin insiders must abide by specific rules, including filing SEC forms every time they buy or sell Nu Skin'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Edwina Woodbury over three months ago Acquisition by Edwina Woodbury of tradable shares of Nu Skin at 7.62 subject to Rule 16b-3 | ||
Edwina Woodbury over six months ago Acquisition by Edwina Woodbury of tradable shares of Nu Skin at 13.07 subject to Rule 16b-3 | ||
Edwina Woodbury over six months ago Disposition of 1693 shares by Edwina Woodbury of Nu Skin at 12.02 subject to Rule 16b-3 | ||
Edwina Woodbury over six months ago Acquisition by Edwina Woodbury of tradable shares of Nu Skin at 12.82 subject to Rule 16b-3 |
Nu Skin Management Efficiency
The company has Return on Asset of 0.0555 % which means that on every $100 spent on assets, it made $0.0555 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.135) %, meaning that it generated no profit with money invested by stockholders. Nu Skin's management efficiency ratios could be used to measure how well Nu Skin manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.01 in 2025. Return On Capital Employed is likely to drop to 0.04 in 2025. At this time, Nu Skin's Non Current Assets Total are comparatively stable compared to the past year. Non Currrent Assets Other is likely to gain to about 104.3 M in 2025, whereas Other Current Assets are likely to drop slightly above 69.5 M in 2025.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Maria Otero | Herbalife Nutrition | 70 | |
| Gary Hendrickson | Polaris Industries | 64 | |
| Jonathan Christodoro | Herbalife Nutrition | 43 | |
| Donal Mulligan | Herbalife Nutrition | 60 | |
| Andrew Masuda | USANA Health Sciences | N/A | |
| Kevin Farr | Polaris Industries | 63 | |
| Nicholas Graziano | Herbalife Nutrition | 47 | |
| Peggie Pelosi | USANA Health Sciences | 65 | |
| Annette Clayton | Polaris Industries | 56 | |
| David Singer | Flowers Foods | 64 | |
| Bernd Kessler | Polaris Industries | 62 | |
| Hunter Gary | Herbalife Nutrition | 44 | |
| James Nelson | Herbalife Nutrition | 69 | |
| Darryl Jackson | Polaris Industries | 60 | |
| Margarita PalauHernandez | Herbalife Nutrition | 63 | |
| Rhonda Gass | Flowers Foods | 56 | |
| John Tartol | Herbalife Nutrition | 69 | |
| Richard Carmona | Herbalife Nutrition | 71 | |
| Feng Peng | USANA Health Sciences | 46 | |
| Gwynne Shotwell | Polaris Industries | 57 | |
| Lawrence Kingsley | Polaris Industries | 58 | |
Management Performance
| Return On Equity | -0.13 | ||||
| Return On Asset | 0.0555 |
Nu Skin Enterprises Leadership Team
Elected by the shareholders, the Nu Skin's board of directors comprises two types of representatives: Nu Skin inside directors who are chosen from within the company, and outside directors, selected externally and held independent of NUS. The board's role is to monitor Nu Skin's management team and ensure that shareholders' interests are well served. Nu Skin's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nu Skin's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Scott Pond, Director - Investor Relations | ||
| Ritch Wood, CFO, Principal Accounting Officer and VP | ||
| Chayce Clark, Executive Vice President General Counsel | ||
| Joseph Chang, Executive Vice President - Product Development, Chief Scientific Officer | ||
| Ruth Todd, Senior Officer | ||
| Emma Battle, Director | ||
| Thomas Pisano, Independent Director | ||
| Mark Adams, Chief Officer | ||
| Zheqing Shen, Independent Director | ||
| James Thomas, Chief Accounting Officer | ||
| Mang Tang, Strategic Advisor | ||
| Joe Sueper, Senior CTO | ||
| Mark Lawrence, Chief Financial Officer, Executive Vice President | ||
| Sandra Tillotson, Founder | ||
| D Dorny, Executive Vice President, General Counsel, Secretary | ||
| Steve Hatchett, Executive Officer | ||
| Daniel Campbell, Lead Independent Director | ||
| Edwina Woodbury, Independent Director | ||
| Laura Nathanson, Independent Director | ||
| Steven Lund, Executive Chairman of the Board | ||
| Matthew Dorny, VP, General Counsel and Secretary | ||
| Connie Tang, Executive Vice President Chief Global Growth & customer Experience Officer | ||
| Justin Keisel, President Americas | ||
| Blake Roney, Founder | ||
| Steven JD, CoFounder Board | ||
| Andrew Lipman, Independent Director | ||
| Greg Belliston, Assistant Secretary | ||
| Ryan Napierski, President, Chief Executive Officer, Director |
NUS Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Nu Skin a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.13 | ||||
| Return On Asset | 0.0555 | ||||
| Profit Margin | (0.06) % | ||||
| Operating Margin | 0.04 % | ||||
| Current Valuation | 607 M | ||||
| Shares Outstanding | 49.71 M | ||||
| Shares Owned By Insiders | 2.29 % | ||||
| Shares Owned By Institutions | 79.89 % | ||||
| Number Of Shares Shorted | 2.34 M | ||||
| Price To Earning | 10.70 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for NUS Stock Analysis
When running Nu Skin's price analysis, check to measure Nu Skin's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nu Skin is operating at the current time. Most of Nu Skin's value examination focuses on studying past and present price action to predict the probability of Nu Skin's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nu Skin's price. Additionally, you may evaluate how the addition of Nu Skin to your portfolios can decrease your overall portfolio volatility.